Xiangping Qian - Foster City CA, US Gustave Bergnes - Pacifica CA, US Dashyant Dhanak - West Chester PA, US Steven D. Knight - West Chester PA, US Nicholas D. Adams - Royersford PA, US Cynthia A. Parrish - King of Prussia PA, US
Assignee:
Cytokinetics, Inc. - South San Francisco CA SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C07D 471/02 A61K 31/4439
US Classification:
514300, 546121
Abstract:
Provided herein are certain substituted N-phenethylbenzamide of formula V:.
Xiangping Qian - Foster City CA, US Luke W. Ashcraft - San Francisco CA, US Jianchao Wang - Foster City CA, US Bing Yao - Millbrae CA, US Hong Jiang - Palo Alto CA, US Gustave Bergnes - Pacifica CA, US Bradley P. Morgan - Moraga CA, US Dashyant Dhanak - West Chester PA, US Steven D. Knight - West Chester PA, US Nicholas D. Adams - Royersford PA, US Cynthia A. Parrish - Philadelphia PA, US Kevin J. Duffy - Philadelphia PA, US Duke Fitch - Spring City PA, US Rosanna Tedesco - Philadelphia PA, US
Assignee:
Cytokinetics, Incorporated - South San Francisco CA SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 31/4178 C07D 403/10
US Classification:
514397, 5483147
Abstract:
Provided are compounds of Formula I and pharmaceutically acceptable salts thereof which may be useful for the treatment of cancer or other proliferative disorders.
Yanhong Feng - Collegeville PA, US Cynthia A. Parrish - Collegeville PA, US Martha A Sarpong - Collegeville PA, US Domingos J Silva - Collegeville CA, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 31/498
US Classification:
514249, 544353
Abstract:
Invented is a method of inhibiting the activity/function of PI3 kinases using quinoxaline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoxaline derivatives.
Xiangping Qian - South San Francisco CA, US Andrew I. McDonald - South San Francisco CA, US Han-Jie Zhou - South San Francisco CA, US Luke W. Ashcraft - South San Francisco CA, US Bing Yao - South San Francisco CA, US Hong Jiang - South San Francisco CA, US Jennifer Kuo Chen Huang - South San Francisco CA, US Jianchao Wang - South San Francisco CA, US Bradley P. Morgan - South San Francisco CA, US Gustave Bergnes - South San Francisco CA, US Dashyant Dhanak - Philadelphia PA, US Steven D. Knight - Philadelphia PA, US Nicholas D. Adams - Philadelphia PA, US Cynthia A. Parrish - Philadelphia PA, US Kevin Duffy - Philadelphia PA, US Duke Fitch - Philadelphia PA, US Rosanna Tedesco - Philadelphia PA, US
Assignee:
Cytokinetics, Inc. - South San Fransico CA SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C07D 471/02 A61K 31/4439
US Classification:
514300, 546121
Abstract:
Provided are compounds of Formula V and pharmaceutically acceptable salts thereof which may be useful for the treatment of cancer or other proliferative disorders.
Xiangping Qian - South San Francisco CA, US Andrew I. McDonald - South San Francisco CA, US Han-Jie Zhou - South San Francisco CA, US Luke W. Ashcraft - South San Francisco CA, US Bing Yao - South San Francisco CA, US Hong Jiang - South San Francisco CA, US Jennifer Kuo Chen Huang - South San Francisco CA, US Jianchao Wang - South San Francisco CA, US Bradley P. Morgan - South San Francisco CA, US Gustave Bergnes - South San Francisco CA, US Dashyant Dhanak - Philadelphia PA, US Steven D. Knight - Philadelphia PA, US Nicholas D. Adams - Philadelphia PA, US Cynthia A. Parrish - Philadelphia PA, US Kevin Duffy - Philadelphia PA, US Duke Fitch - Philadelphia PA, US Rosanna Tedesco - Philadelphia PA, US
Assignee:
Cytokinetics, Incorporated - South San Francisco CA
International Classification:
C07D 233/64 C07D 231/12 A61K 31/415 A61K 31/4164
US Classification:
5483381, 5483751, 514399, 514406
Abstract:
Provided are compounds of Formula V and pharmaceutically acceptable salts thereof which may be useful for the treatment of cancer or other proliferative disorders.
Xiangping Qian - South San Francisco CA, US Andrew I. McDonald - South San Francisco CA, US Han-Jie Zhou - South San Francisco CA, US Luke W. Ashcraft - South San Francisco CA, US Bing Yao - South San Francisco CA, US Hong Jiang - South San Francisco CA, US Jennifer Kuo Chen Huang - South San Francisco CA, US Jianchao Wang - South San Francisco CA, US Bradley P. Morgan - South San Francisco CA, US Gustave Bergnes - South San Francisco CA, US Dashyant Dhanak - Philadelphia PA, US Steven D. Knight - Philadelphia PA, US Nicholas D. Adams - Philadelphia PA, US Cynthia A. Parrish - Philadelphia PA, US Kevin Duffy - Philadelphia PA, US Duke Fitch - Philadelphia PA, US Rosanna Tedesco - Philadelphia PA, US
Assignee:
Cytokinetics, Incorporated - South San Francisco CA
International Classification:
C07D 471/02 A61K 31/4439
US Classification:
546121, 514300
Abstract:
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
Xiangping Qian - South San Francisco CA, US Andrew I. McDonald - San Francisco CA, US Han-Jie Zhou - San Francisco CA, US Luke W. Ashcraft - South San Francisco CA, US Bing Yao - South San Francisco CA, US Hong Jiang - South San Francisco CA, US Jennifer Kuo Chen Huang - South San Francisco CA, US Jianchao Wang - South San Francisco CA, US Bradley P. Morgan - South San Francisco CA, US Gustave Bergnes - South San Francisco CA, US Dashyant Dhanak - Philadelphia PA, US Steven D. Knight - Philadelphia PA, US Nicholas D. Adams - Philadelphia PA, US Cynthia A. Parrish - Philadelphia PA, US Kevin Duffy - Philadelphia PA, US Duke Fitch - Philadelphia PA, US Rosanna Tedesco - Philadelphia PA, US
Assignee:
Cytokinetics, Incorporated - South San Francisco CA
International Classification:
C07D 471/02 A61K 31/47
US Classification:
546121, 514300
Abstract:
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.